Structural and functional integrity of human serum albumin: Analytical approaches and clinical relevance in patients with liver cirrhosis

被引:41
|
作者
Naldi, Marina [1 ,2 ]
Baldassarre, Maurizio [2 ,3 ]
Domenicali, Marco [2 ,3 ]
Bartolini, Manuela [1 ]
Caraceni, Paolo [2 ,3 ]
机构
[1] Alma Mater Studiorum Univ Bologna, Dept Pharm & Biotechnol, Via Belmeloro 6, I-40126 Bologna, Italy
[2] St Orsola Marcello Malpighi Hosp, CRBA, Via Massarenti 9, I-40138 Bologna, Italy
[3] Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Via Massarenti 9, I-40138 Bologna, Italy
关键词
Human serum albumin; Non-oncotic properties; Post-translational modifications; Liver cirrhosis; Liquid chromatography-mass spectrometry; Spectroscopic methods; ISCHEMIA-MODIFIED ALBUMIN; PERFORMANCE AFFINITY-CHROMATOGRAPHY; ELECTROPHORESIS-MASS SPECTROMETRY; CAPILLARY-ZONE-ELECTROPHORESIS; TOTAL ANTIOXIDANT CAPACITY; DRUG-BINDING PROPERTIES; 3 RECOMBINANT DOMAINS; REDOX STATE; OXIDATIVE STRESS; PROTEIN-BINDING;
D O I
10.1016/j.jpba.2017.04.023
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Human serum albumin (HSA) is the most abundant circulating plasma protein. Besides a significant contribution to the osmotic pressure, it is also involved in the fine regulation of many other physiological processes, including the balance of the redox state, the inflammatory and/or immunological responses, and the pharmacokinetic and pharmacodynamics of many drugs. Growing evidence suggests that HSA undergoes structural and functional damage in diseases characterized by an enhanced systemic inflammatory response and oxidative stress, as it occurs in chronic liver disease. Based on their clinical relevance, this review provides a summary of the most common post-translational modifications affecting HSA structural integrity and functions and their clinical relevance in the field of liver disease. The review also provides a critical description of the analytical approaches employed for the investigation of conformational alterations and the identification/quantitati on of specific post-translational modifications affecting HSA. Finally, the analytical methods available for the assessment of two of the most clinically relevant non-oncotic properties of HSA, namely the binding capacity and the antioxidant activity, are critically reviewed. Among the available techniques particular attention is given to those proposed for the in vitro and in vivo investigation of structurally modified albumin. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:138 / 153
页数:16
相关论文
共 50 条
  • [1] AN EVALUATION OF HUMAN SERUM ALBUMIN IN THE TREATMENT OF CIRRHOSIS OF THE LIVER
    FALOON, WW
    ECKHARDT, RD
    MURPHY, TL
    COOPER, AM
    DAVIDSON, CS
    JOURNAL OF CLINICAL INVESTIGATION, 1949, 28 (04): : 583 - 594
  • [2] A comparative pharmacokinetic study of recombinant human serum albumin with plasma-derived human serum albumin in patients with liver cirrhosis
    Ohnishi, Kunihiko
    Kawagucbi, Atsuhiro
    Nakajimo, Shunji
    Mori, Hiroyuki
    Ueshima, Takahiro
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (02): : 203 - 208
  • [3] Clinical and prognostic relevance of albumin dimers in patients with cirrhosis: a novel identified structural alteration of the molecule
    Baldassarre, Maurizio
    Domenicali, Marco
    Giannone, Ferdinando A.
    Naldi, Marina
    Laggetta, Maristella
    Patrono, Daniela
    Bertucci, Carlo
    Bernardi, Mauro
    Caraceni, Paolo
    HEPATOLOGY, 2014, 60 : 478A - 479A
  • [4] Albumin Homodimers in Patients with Cirrhosis: Clinical and Prognostic Relevance of a Novel Identified Structural Alteration of the Molecule
    Baldassarre, Maurizio
    Domenicali, Marco
    Naldi, Marina
    Laggetta, Maristella
    Giannone, Ferdinando A.
    Biselli, Maurizio
    Patrono, Daniela
    Bertucci, Carlo
    Bernardi, Mauro
    Caraceni, Paolo
    SCIENTIFIC REPORTS, 2016, 6
  • [5] CLINICAL AND PROGNOSTIC RELEVANCE OF ALBUMIN DIMERS IN PATIENTS WITH CIRRHOSIS: A NOVEL IDENTIFIED STRUCTURAL ALTERATION OF THE MOLECULE
    Baldassarre, M.
    Domenicali, M.
    Giannone, F. A.
    Naldi, M.
    Laggetta, M.
    Patrono, D.
    Bertucci, C.
    Bernardi, M.
    Caraceni, P.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E130 - E130
  • [6] Albumin Homodimers in Patients with Cirrhosis: Clinical and Prognostic Relevance of a Novel Identified Structural Alteration of the Molecule
    Maurizio Baldassarre
    Marco Domenicali
    Marina Naldi
    Maristella Laggetta
    Ferdinando A. Giannone
    Maurizio Biselli
    Daniela Patrono
    Carlo Bertucci
    Mauro Bernardi
    Paolo Caraceni
    Scientific Reports, 6
  • [7] THE USE OF CONCENTRATED HUMAN SERUM ALBUMIN IN THE TREATMENT OF CIRRHOSIS OF THE LIVER
    KUNKEL, HG
    LABBY, DH
    AHRENS, EH
    SHANK, RE
    HOAGLAND, CL
    JOURNAL OF CLINICAL INVESTIGATION, 1948, 27 (03): : 305 - 319
  • [8] SERUM ALBUMIN- BINDING CAPACITY CORRELATES WITH SERUM ALBUMIN STRUCTURAL ALTERATIONS AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTELY DECOMPENSATED CIRRHOSIS AND ACUTE- ONCHRONIC LIVER FAILURE
    Zhang, Chenxi
    Lu, Yide
    An, Baoyan
    Meng, Shuang
    Chen, Yaoxing
    Cai, Minghao
    Fu, Haoshuang
    Lu, Jie
    Li, Ziqiang
    Qian, Zhuping
    Xia, Li
    Xin, Haiguang
    Cao, Zhujun
    Xie, Qing
    HEPATOLOGY, 2024, 80 : S213 - S214
  • [9] Repeated administration of recombinant human serum albumin caused no serious allergic reactions in patients with liver cirrhosis: a multicenter clinical study
    Kasahara, Akinori
    Kita, Keiji
    Tomita, Eijchi
    Toyota, Jouji
    Imai, Yasuharu
    Kumada, Hiromitsu
    JOURNAL OF GASTROENTEROLOGY, 2008, 43 (06) : 464 - 472
  • [10] Repeated administration of recombinant human serum albumin caused no serious allergic reactions in patients with liver cirrhosis: a multicenter clinical study
    Akinori Kasahara
    Keiji Kita
    Eiichi Tomita
    Jouji Toyota
    Yasuharu Imai
    Hiromitsu Kumada
    Journal of Gastroenterology, 2008, 43 : 464 - 472